The Leukemia & Lymphoma Society

194 articles with The Leukemia & Lymphoma Society

• Verastem Oncology Announces Collaboration with The Leukemia & Lymphoma Society to Accelerate Development of Duvelisib for the Treatment of Peripheral T-Cell Lymphoma

  11/7/2018

  Verastem, Inc. today announced a collaboration with The Leukemia & Lymphoma Society® (LLS), to accelerate the development of duvelisib for the treatment of patients with peripheral T-cell lymphoma

• New Study Demonstrates Burdensome Cost Of Blood Cancer Care

  10/29/2018

  The costs to treat a blood cancer are higher than costs for other cancers, and the costs incurred by a patient diagnosed with a blood cancer do not return to pre-cancer levels, according to a Milliman study commissioned by The Leukemia & Lymphoma Society (LLS).

• 

  Syros Pharma and Genentech: Corporate Culture Enhanced and Defined by Non-Work Activities

  10/25/2018

  What is presumably good humor, Cambridge, Mass.-based Syros Pharmaceuticals held its third annual Lab Olympics, where various executives in the company competed in a range of contests that included a race to put on safety equipment and accuracy in pipetting.

• The Leukemia & Lymphoma Society Receives Significant Gift to Support Promising Young Scientists

  10/10/2018

  Schwartz Ward Family Foundation commits $1,175,000 to research in CAR T-cell immunotherapy in myeloma and novel therapy for lymphoma

• Cancer Is Tough, But The Leukemia & Lymphoma Society (LLS) Is Tougher

  8/28/2018

  LLS is leading the way to cancer cures, during Blood Cancer Awareness Month and beyond

• Sutro and The Leukemia & Lymphoma Society Partner on Lymphoma and Multiple Myeloma Treatment

  8/13/2018

  Sutro Biopharma, Inc., and The Leukemia & Lymphoma Society® , or LLS, are partnering to develop STRO-001, Sutro’s CD74-targeting antibody-drug conjugate, to treat relapsed and/or refractory multiple myeloma and non-Hodgkin’s lymphoma.

• Women Score Top Marks in The Leukemia & Lymphoma Society of Canada's 2018 Research Awards

  8/8/2018

  Female scientists lead scorers among 32 grant awardees in annual research competition held by Canada's only nonprofit health agency dedicated to all blood cancers.

• The Leukemia & Lymphoma Society Greater Bay Area Chapter to Host World Class Sailing Event with Notable Speakers

  8/2/2018

  The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter will host the Leukemia Cup Regatta on October 20 and 21 at the Corinthian Yacht Club in Tiburon, CA.

• The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Appointments and New Chief Operating Officer

  7/10/2018

  World's largest blood cancer non-profit boasts addition of leading cancer researchers in its commitment to finding cures

• The Leukemia & Lymphoma Society's Man & Woman of the Year Campaign Breaks Fundraising Records for Cancer Cures

  7/9/2018

  10-week philanthropic competition raises $45 million

• Bring light to someone who has been touched by the darkness of cancer on National Random Acts of Light Day, June 13

  6/12/2018

  The Leukemia & Lymphoma Society celebrates year three of movement to support cancer patients and survivors; US Air Force vet surprised and honored at professional soccer event

• High School Students 'Test' the Limits of Philanthropy

  6/7/2018

  The Leukemia & Lymphoma Society creates new generation of givers through unique Students of the Year Campaign

• More Progress on LLS-Supported CAR T-cell Immunotherapy, A Revolutionary Approach to Cancer Treatment

  5/2/2018

  The U.S. Food and Drug Administration (FDA) granted tisagenlecleucel (Kymriah®) its second approval to treat patients with diffuse large B-cell lymphoma (DLBCL).

• Leukemia Patient's Legacy Helps Drive Innovative Cancer Clinical Trial

  3/21/2018

  The Harry T. Mangurian Jr. Foundation continues to fuel The Leukemia & Lymphoma Society (LSS) ambitious attack on this deadly blood cancer.

• The Time is Now for More Women in Science

  3/13/2018

  The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances.

• Commitment to Curing Cancer: High School Fundraising Campaign Raises $192,000+ in Seven Weeks For The Leukemia & Lymphoma Society

  3/2/2018

  Arnav Verma and Anoushka Dave of Team Cut Out Cancer named 2018 Students of the Year winners.

• The Leukemia Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer

  12/6/2017

  More than 150 patients are now enrolled in this innovative trial which aims to find new treatments for a blood cancer that has not seen significant treatment improvements in almost 40 years.

• Neximmune and the Leukemia & Lymphoma Society Enter Partnership for the Development of AIM ACT in AML Patients

  10/17/2017

  This will advance the Company’s novel cellular immunotherapy into Phase I clinical testing for patients with high risk AML who have relapsed after an allogeneic hematopoietic stem cell transplant.

• The Leukemia & Lymphoma Society Release: FDA Approval Of Targeted Therapy For Acute Myeloid Leukemia Is A Significant Advance For Deadly Blood Cancer

  9/5/2017

• Selvita And The Leukemia & Lymphoma Society Announce Partnership To Advance SEL120 Into Phase I For AML Patients

  8/8/2017